Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

Literature DB >> 14671630

Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

F Ayuk, A Shimoni, A Nagler, R Schwerdtfeger, M Kiehl, H G Sayer, T Zabelina, A R Zander, N Kröger.

Abstract

Entities: Disease Species

Mesh：

Year: 2004 PMID： 14671630 DOI： 10.1038/sj.leu.2403252

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors: David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal: Biol Blood Marrow Transplant Date: 2010-08-10 Impact factor: 5.742

Review 2. Promising role of reduced-toxicity hematopoietic stem cell transplantation (PART-I).

Authors: S Abdul Wahid Fadilah; Md Pazil Aqilah
Journal: Stem Cell Rev Rep Date: 2012-12 Impact factor: 5.739

3. Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

Authors: Kenneth C Anderson; Melissa Alsina; Djordje Atanackovic; J Sybil Biermann; Jason C Chandler; Caitlin Costello; Benjamin Djulbegovic; Henry C Fung; Cristina Gasparetto; Kelly Godby; Craig Hofmeister; Leona Holmberg; Sarah Holstein; Carol Ann Huff; Adetola Kassim; Amrita Y Krishnan; Shaji K Kumar; Michaela Liedtke; Matthew Lunning; Noopur Raje; Seema Singhal; Clayton Smith; George Somlo; Keith Stockerl-Goldstein; Steven P Treon; Donna Weber; Joachim Yahalom; Dorothy A Shead; Rashmi Kumar
Journal: J Natl Compr Canc Netw Date: 2015-11 Impact factor: 11.908

4. Excellent proliferation and persistence of allogeneic donor-derived 41-BB based CAR-T cells despite immunosuppression with cyclosporine A.

Authors: Francis Ayuk; Boris Fehse; Dietlinde Janson; Carolina Berger; Kristoffer Riecken; Nicolaus Kröger
Journal: Haematologica Date: 2020-04-02 Impact factor: 9.941

Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

1. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Review 2. Promising role of reduced-toxicity hematopoietic stem cell transplantation (PART-I).

3. Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

4. Excellent proliferation and persistence of allogeneic donor-derived 41-BB based CAR-T cells despite immunosuppression with cyclosporine A.

Review 5. Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

6. Epigenetic therapy in allogeneic hematopoietic stem cell transplantation.

7. Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children.